RxDoctor Payments Data

Jane Chen, MD

Clinical Cardiac Electrophysiology · Minneapolis, MNNPI 1093732547

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $29,838 of the $45,796 with a category attached, or 65.2%. Medtronic accounts for 60.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $17,835 and has fallen 99.9% since, to $24 in 2025.

$45,796in general payments, 2019–2025

Across 133 payments — averaging $344.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$28K
  • Abbott$13K
  • Biotronik Inc.$3K
  • Braemar Manufacturing, LLC$2K
  • Boston Scientific$261
  • Biosense Webster, Inc.$15
$11,445in research payments, 2019–2025

Across 4 payments — averaging $2861.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$11K

What the payments were for

  • Consulting fees$7,13816%
  • Speaking & faculty fees$29,83865%
  • Travel & lodging$4,2859%
  • Food & beverage$4,53710%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)71$27,894
Abbott47$12,601
Biotronik Inc.8$3,025
Braemar Manufacturing, LLC1$2,000
Boston Scientific5$261
Biosense Webster, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,796 in reported general payments places this provider in the 80th percentile of 72 clinical cardiac electrophysiology providers in Minnesota.

See all clinical cardiac electrophysiology providers in Minnesota

Medicare billing

Part B allowed, 2024
$40,250
Medicare patients
740
Services billed
1,371

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban176$198,774
XareltoRivaroxaban31$36,336
Flecainide Acetate35$1,880
Metoprolol Succinate99$1,686
Amiodarone Hcl32$1,165
SotalolSotalol Hcl36$1,103
Atorvastatin Calcium43$869
Carvedilol48$829
Lisinopril30$546
Warfarin Sodium24$527
Losartan Potassium17$260
Metoprolol Tartrate18$245
Amlodipine Besylate13$86

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →